TVGN · Tevogen Bio Holdings Inc.
$5.04
+0.90 (+21.59%)
At close · Jul 27
Market Cap
$18.80M
Shares
4.19M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$26.28M
-91.4%
FY2025
Diluted EPS
-$8.08
-130.9%
FY2025
Operating Cash Flow
-$12.33M
-2.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| -$242.21K | -$195.62K | -$184.04K | — | — | — | |
| $11.05M | $11.11M | $31.03M | $4.4M | — | — | |
| $10.13M | $15.03M | $22.53M | $4.44M | $953.08K | $181.42K | |
| $21.19M | $26.14M | $53.56M | $8.84M | — | — | |
| $29.47M | — | — | $2.27M | $953.08K | $181.42K | |
| -$21.19M | -$26.14M | -$53.56M | -$8.84M | — | — | |
| — | — | $184.04K | $1.21M | — | — | |
| — | — | — | $2.73M | $4.95M | $15.81K | |
| — | — | — | $2.21M | $5.36M | $152.68K | |
| — | $4750 | $1750 | — | — | — | |
| -$21.35M | -$26.28M | -$13.73M | -$60.48M | $4.41M | -$28.75K | |
| -$21.94M | -$26.83M | -$10.27M | -$60.48M | — | — | |
| USD/shares | — | -$8.08 | -$3.50 | -$122.00 | — | — |
| USD/shares | — | -$8.08 | -$3.50 | -$122.00 | — | — |
| shares | — | 3.32M | 2.93M | 495.04K | — | — |
| shares | — | 3.32M | 2.93M | 495.04K | — | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 20.87×
EV/EBIT
—
P/E (TTM)
—
Peer median 0.17×
Peer medians compare against the 239 similar-size Biotechnology companies (of 521 listed).